• All
  • Primary Antibodies
  • Conjugated Antibodies for IF
  • Conjugated Antibodies for FC
  • Secondary Antibodies
  • Antibody Labeling KitsNew
  • ELISA Kits
  • IHC Kits
  • Magnetic Cell Separation Kits
  • Cytokines & Growth Factors
  • Neutralizing/activating Antibodies
  • Nanobody-based Reagents
  • Accessory Products and Kits
  • Fusion Proteins
×
×
Host
0
Species Reactivity
0
Species Reactivity
0
Conjugate
0
Conjugate
0
Compatible Species
0
Conjugate
0

LPAR1,EDG2 Rekombinanter Antikörper

LPAR1,EDG2 Rekombinant Antikörper für WB, Indirect ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human

Anwendung

WB, Indirect ELISA

Konjugation

Unkonjugiert

CloneNo.

251542A6

Kat-Nr. : 86655-2-PBS

Synonyme

LPAR1, edg 2, EDG2, Gpcr26, GPR26

Filter:
  • Western Blot (WB) analysis of various lysates using LPAR1,EDG2 Recombinant monoclonal antibody (86655-2-RR)

    WB analysis using 86655-2-RR (same clone as 86655-2-PBS)

    Various lysates were subjected to SDS PAGE followed by western blot with 86655-2-RR (LPAR1,EDG2 antibody) at dilution of 1:3000 incubated at room temperature for 1.5 hours. This data was developed using the same antibody clone with 86655-2-PBS in a different storage buffer formulation.

Geprüfte Anwendungen

Produktinformation

86655-2-PBS bindet in WB, Indirect ELISA LPAR1,EDG2 und zeigt Reaktivität mit human

Getestete Reaktivität human
Wirt / Isotyp Kaninchen / IgG
Klonalität Rekombinant
Typ Antikörper
Immunogen Peptid
Vollständiger Name lysophosphatidic acid receptor 1
Berechnetes Molekulargewicht 364 aa, 41 kDa
Beobachtetes Molekulargewicht50 kDa
GenBank-ZugangsnummerBC030615
Gene symbol EDG2
Gene ID (NCBI) 1902
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Protein-A-Reinigung
Lagerungspuffer PBS only
LagerungsbedingungenStore at -80°C. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

EDG2 (also known as LPA1) is a G-protein coupled receptor for lysophosphatidic acid (LPA), a potent motility inducing factor, which is a major component of serum (PMID: 19415462). EDG2 is widely expressed in normal tissue during growth and development. In the context of cancer, several studies have suggested that EDG2 expression in tumors is often similar to that shown in normal tissue (PMID: 17496233).